Apogee Therapeutics Statistics
Total Valuation
APGE has a market cap or net worth of $2.17 billion. The enterprise value is $1.57 billion.
Important Dates
The last earnings date was Monday, August 11, 2025, before market open.
Earnings Date | Aug 11, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
APGE has 58.57 million shares outstanding. The number of shares has increased by 17.27% in one year.
Current Share Class | 45.08M |
Shares Outstanding | 58.57M |
Shares Change (YoY) | +17.27% |
Shares Change (QoQ) | +0.40% |
Owned by Insiders (%) | 2.12% |
Owned by Institutions (%) | 86.79% |
Float | 37.79M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 3.61 |
P/TBV Ratio | 3.51 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 16.36, with a Debt / Equity ratio of 0.02.
Current Ratio | 16.36 |
Quick Ratio | 16.15 |
Debt / Equity | 0.02 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -34.12% and return on invested capital (ROIC) is -24.04%.
Return on Equity (ROE) | -34.12% |
Return on Assets (ROA) | -23.21% |
Return on Invested Capital (ROIC) | -24.04% |
Return on Capital Employed (ROCE) | -43.25% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.21M |
Employee Count | 196 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, APGE has paid $173,000 in taxes.
Income Tax | 173,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -23.29% in the last 52 weeks. The beta is 1.43, so APGE's price volatility has been higher than the market average.
Beta (5Y) | 1.43 |
52-Week Price Change | -23.29% |
50-Day Moving Average | 38.70 |
200-Day Moving Average | 39.64 |
Relative Strength Index (RSI) | 48.15 |
Average Volume (20 Days) | 444,234 |
Short Selling Information
The latest short interest is 9.12 million, so 15.58% of the outstanding shares have been sold short.
Short Interest | 9.12M |
Short Previous Month | 8.40M |
Short % of Shares Out | 15.58% |
Short % of Float | 24.15% |
Short Ratio (days to cover) | 14.38 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -270.83M |
Pretax Income | -103.55M |
Net Income | -237.67M |
EBITDA | -270.10M |
EBIT | -270.83M |
Earnings Per Share (EPS) | -$4.12 |
Full Income Statement Balance Sheet
The company has $505.42 million in cash and $10.85 million in debt, giving a net cash position of $610.34 million or $10.42 per share.
Cash & Cash Equivalents | 505.42M |
Total Debt | 10.85M |
Net Cash | 610.34M |
Net Cash Per Share | $10.42 |
Equity (Book Value) | 619.40M |
Book Value Per Share | 10.58 |
Working Capital | 484.57M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$220.74 million and capital expenditures -$5.84 million, giving a free cash flow of -$226.58 million.
Operating Cash Flow | -220.74M |
Capital Expenditures | -5.84M |
Free Cash Flow | -226.58M |
FCF Per Share | -$3.87 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
APGE does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -17.27% |
Shareholder Yield | -17.27% |
Earnings Yield | -10.92% |
FCF Yield | -10.41% |
Analyst Forecast
The average price target for APGE is $95.40, which is 156.94% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $95.40 |
Price Target Difference | 156.94% |
Analyst Consensus | Strong Buy |
Analyst Count | 5 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | 10.99% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |